BRPI0408770A - kit para uso farmacêutico - Google Patents
kit para uso farmacêuticoInfo
- Publication number
- BRPI0408770A BRPI0408770A BRPI0408770-4A BRPI0408770A BRPI0408770A BR PI0408770 A BRPI0408770 A BR PI0408770A BR PI0408770 A BRPI0408770 A BR PI0408770A BR PI0408770 A BRPI0408770 A BR PI0408770A
- Authority
- BR
- Brazil
- Prior art keywords
- nutrient
- administered
- once
- active ingredient
- active
- Prior art date
Links
- 235000015097 nutrients Nutrition 0.000 abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 3
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Medical Informatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Accommodation For Nursing Or Treatment Tables (AREA)
- Exchange Systems With Centralized Control (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Packages (AREA)
- Telephone Function (AREA)
Abstract
"KIT PARA USO FARMACêUTICO". A presente invenção refere-se a kit para a promoção da administração oral, em seqüência adequada, de um ingrediente farmaceuticamente ativo e nutrientes associados, o qual inclui: (a) ao menos uma dose unitária de um ativo farmacêutico a ser administrado continuamente, com uma freqüência de uma vez por semana, duas vezes por semana, uma vez a cada duas semanas, duas vezes por mês, ou uma vez por mês; (b) ao menos uma dose unitária de um nutriente a ser administrado subseqüentemente à administração da dose do ativo; e (c) uma cartela blister contendo, individualmente e de modo liberável, as doses unitárias; sendo que as ditas doses unitárias de ativo farmacêutico e de nutriente estão dispostas de maneira horizontal ou vertical, em sua ordem de uso, ao longo da cartela blister, o que é útil para auxiliar no entendimento e na adesão, por parte do paciente, quanto aos regimes de dosagem nos quais o ingrediente ativo é administrado com uma freqüência contínua outra que não diária, e nos quais o nutriente é administrado nos dias intercalados àqueles em que é administrado o ingrediente ativo.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45786503P | 2003-03-26 | 2003-03-26 | |
| US60/457,865 | 2003-03-26 | ||
| PCT/US2004/009595 WO2004087038A1 (en) | 2003-03-26 | 2004-03-26 | Kit for pharmaceutical use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0408770A true BRPI0408770A (pt) | 2006-04-04 |
| BRPI0408770B1 BRPI0408770B1 (pt) | 2021-06-01 |
Family
ID=33131725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0408770-4A BRPI0408770B1 (pt) | 2003-03-26 | 2004-03-26 | Kit para a promoção da adminstração oral de bisfosfonato e de um nutriente |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US20040188316A1 (pt) |
| EP (1) | EP1605890B1 (pt) |
| JP (1) | JP4865332B2 (pt) |
| KR (1) | KR100775795B1 (pt) |
| CN (1) | CN100493486C (pt) |
| AT (1) | ATE526003T1 (pt) |
| AU (1) | AU2004226326B2 (pt) |
| BR (1) | BRPI0408770B1 (pt) |
| CA (1) | CA2517102A1 (pt) |
| CO (1) | CO5650216A2 (pt) |
| CY (1) | CY1112964T1 (pt) |
| DK (1) | DK1605890T5 (pt) |
| ES (1) | ES2374273T3 (pt) |
| HR (1) | HRP20050824B1 (pt) |
| HU (1) | HU3526U (pt) |
| IL (1) | IL170830A (pt) |
| IS (1) | IS2883B (pt) |
| MA (1) | MA27723A1 (pt) |
| MX (1) | MXPA05010198A (pt) |
| NO (1) | NO333084B1 (pt) |
| NZ (1) | NZ541856A (pt) |
| PL (1) | PL1605890T3 (pt) |
| PT (1) | PT1605890E (pt) |
| RU (1) | RU2314786C2 (pt) |
| SI (1) | SI1605890T1 (pt) |
| WO (1) | WO2004087038A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2294203C2 (ru) * | 2001-12-21 | 2007-02-27 | Дзе Проктер Энд Гэмбл Компани | Способ лечения костных нарушений |
| US20050070504A1 (en) * | 2001-12-21 | 2005-03-31 | The Procter & Gamble Co. | Risedronate compositions and their methods of use |
| US20070095850A1 (en) * | 2005-10-27 | 2007-05-03 | Meyer Daniel D | Multiple medication dispensing system |
| KR100844256B1 (ko) * | 2007-03-23 | 2008-07-07 | 코오롱제약주식회사 | 리세드로네이트와 비타민 ｄ를 포함하는 대사성 골질환치료용 약제조성물 및 이의 제조방법 |
| WO2009087553A1 (en) * | 2008-01-02 | 2009-07-16 | Aurobindo Pharma Limited | Kits for administering bisphosphonates |
| EP2082717A1 (en) | 2008-01-28 | 2009-07-29 | Merz Pharma GmbH & Co. KGaA | Titration package |
| TR200900880A2 (tr) * | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Tek bir dozaj formunda kombine edilen farmasötik bileşimler. |
| TR200900879A2 (tr) * | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler |
| ES2587977T3 (es) * | 2009-05-01 | 2016-10-28 | Celloxess Llc | Tratamiento de la infertilidad masculina secundaria al estrés oxidativo de esperma |
| UA20426S (uk) | 2009-06-10 | 2010-05-25 | Тева Фармасьюті& | Упаковка для ліків |
| US20160132658A1 (en) * | 2014-11-09 | 2016-05-12 | Bhuren Patel | Novel multi-compartment dosage cards for split package administration |
| RU2017110012A (ru) * | 2016-05-10 | 2020-06-10 | Анатолий Викторович Зазуля | Устройство для пожизненного приёма переменных доз геропротектора, повышения постадаптации гормезис |
| KR20250136691A (ko) | 2024-03-08 | 2025-09-16 | 서성현 | 잭서포트용 리프트 지그 |
| KR102948936B1 (ko) | 2024-07-31 | 2026-04-07 | 이민주 | 잭서포트용 결합식 리프트 지그 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL58649A (en) * | 1978-11-10 | 1982-04-30 | Beecham Group Ltd | Pharmaceutical dispensing container |
| US4534468A (en) * | 1983-12-19 | 1985-08-13 | Nuckols Walter S | Calendar-oriented pill dispenser |
| US4736849A (en) * | 1983-12-19 | 1988-04-12 | Leonard Walter G | Calendar-oriented pill dispenser |
| US4817819A (en) * | 1985-12-19 | 1989-04-04 | Berlex Laboratories, Inc. | Container for tablets |
| US4958736A (en) * | 1986-03-18 | 1990-09-25 | Gynex, Inc. | Package for oral contraceptive tablet |
| US4889238A (en) * | 1989-04-03 | 1989-12-26 | The Procter & Gamble Company | Medicament package for increasing compliance with complex therapeutic regimens |
| EP0511726B1 (en) | 1991-04-29 | 1997-07-16 | Berlex Laboratories, Inc. | Arrangement for retaining blister pack tablets |
| US5265728A (en) * | 1991-04-29 | 1993-11-30 | Berlex Laboratories, Inc. | Arrangement for retaining blister pack tablets |
| US5366965A (en) * | 1993-01-29 | 1994-11-22 | Boehringer Mannheim Gmbh | Regimen for treatment or prophylaxis of osteoporosis |
| US5484976A (en) * | 1993-10-01 | 1996-01-16 | Axis Usa, Inc. | Fusing methods and apparatus for use in making dynamo-electric machines |
| SE9502370D0 (sv) * | 1995-06-30 | 1995-06-30 | Astra Ab | Blister pack, especially for drugs, as well as method and device in manufacturing the same |
| SE515129C2 (sv) * | 1996-07-01 | 2001-06-11 | Astrazeneca Ab | Blisterförpackning, apparat och förfarande för tillverkning av en blisterförpackning samt användning av en blisterförpackning |
| US5788974A (en) * | 1996-09-11 | 1998-08-04 | D'amico; Steven A. | Helicobacter pylori treatment compliance pack |
| CN1240343A (zh) * | 1996-11-19 | 2000-01-05 | 普罗克特和甘保尔公司 | 配合性包装品和改善或帮助患者对综合药物疗法的配合性的方法 |
| US6564945B1 (en) * | 1997-07-14 | 2003-05-20 | Robert E. Weinstein | Medication assemblage for use in sinusitis treatment regimens |
| US5994329A (en) * | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
| AU1205799A (en) * | 1997-10-29 | 1999-05-17 | J-Med Pharmaceuticals, Inc. | Antihistamine/decongestant regimens for treating rhinitis |
| WO1999051214A2 (en) | 1998-04-07 | 1999-10-14 | Akzo Nobel N.V. | Progestogen-only contraceptive kit |
| US6375956B1 (en) * | 1999-07-22 | 2002-04-23 | Drugtech Corporation | Strip pack |
| AU2270101A (en) * | 1999-12-20 | 2001-07-03 | Merck & Co., Inc. | Pharmaceutical kit |
| US20020066691A1 (en) * | 2000-12-04 | 2002-06-06 | Varon Steven C. | Therapy pack |
| US6651816B2 (en) * | 2001-05-04 | 2003-11-25 | Robert E. Weinstein | Antihistamine/decongestant regimens for treating rhinitis |
| WO2003013270A2 (en) * | 2001-08-09 | 2003-02-20 | Rhodia Inc. | Calcium dietary supplement |
| RU2196494C1 (ru) * | 2001-11-09 | 2003-01-20 | Общество с ограниченной ответственностью "Фабрика медицинской продукции" | Универсальная специализированная аптечка неотложной самопомощи |
| US20030168376A1 (en) * | 2001-12-19 | 2003-09-11 | Rajneesh Taneja | Packaging system for separately storing and dispensing together separate medication components |
| US20030111479A1 (en) * | 2001-12-19 | 2003-06-19 | Rajneesh Taneja | Packaging system for separately storing and dispensing together separate medication components |
-
2004
- 2004-02-27 US US10/789,525 patent/US20040188316A1/en not_active Abandoned
- 2004-03-26 PL PL04758545T patent/PL1605890T3/pl unknown
- 2004-03-26 RU RU2005129534/14A patent/RU2314786C2/ru active
- 2004-03-26 BR BRPI0408770-4A patent/BRPI0408770B1/pt not_active IP Right Cessation
- 2004-03-26 DK DK04758545.0T patent/DK1605890T5/da active
- 2004-03-26 PT PT04758545T patent/PT1605890E/pt unknown
- 2004-03-26 ES ES04758545T patent/ES2374273T3/es not_active Expired - Lifetime
- 2004-03-26 AT AT04758545T patent/ATE526003T1/de active
- 2004-03-26 JP JP2005518922A patent/JP4865332B2/ja not_active Expired - Fee Related
- 2004-03-26 NZ NZ541856A patent/NZ541856A/en not_active IP Right Cessation
- 2004-03-26 HR HRP20050824AA patent/HRP20050824B1/hr not_active IP Right Cessation
- 2004-03-26 EP EP04758545A patent/EP1605890B1/en not_active Expired - Lifetime
- 2004-03-26 WO PCT/US2004/009595 patent/WO2004087038A1/en not_active Ceased
- 2004-03-26 SI SI200431777T patent/SI1605890T1/sl unknown
- 2004-03-26 CA CA002517102A patent/CA2517102A1/en not_active Abandoned
- 2004-03-26 KR KR1020057017720A patent/KR100775795B1/ko not_active Expired - Fee Related
- 2004-03-26 CN CNB2004800079592A patent/CN100493486C/zh not_active Expired - Fee Related
- 2004-03-26 AU AU2004226326A patent/AU2004226326B2/en not_active Ceased
- 2004-03-26 MX MXPA05010198A patent/MXPA05010198A/es active IP Right Grant
-
2005
- 2005-09-09 NO NO20054204A patent/NO333084B1/no not_active IP Right Cessation
- 2005-09-12 IS IS8022A patent/IS2883B/is unknown
- 2005-09-13 CO CO05092523A patent/CO5650216A2/es not_active Application Discontinuation
- 2005-09-13 IL IL170830A patent/IL170830A/en active IP Right Grant
- 2005-09-22 MA MA28508A patent/MA27723A1/fr unknown
-
2006
- 2006-10-03 HU HU20060600225U patent/HU3526U/hu unknown
-
2011
- 2011-12-14 US US13/325,170 patent/US20120145588A1/en not_active Abandoned
- 2011-12-16 CY CY20111101252T patent/CY1112964T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112964T1 (el) | Κιτ για φαρμακευτικη χρηση | |
| RU2356547C2 (ru) | Способы лечения рака с использованием ингибиторов hdac | |
| IT1261849B (it) | Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici. | |
| NZ540385A (en) | Use of 1-oxo-2-(2, 6-dioxopiperidin-3-yl)-4-methylisoindoline in the manufacture of a medicamnent for treatment of brain cancer | |
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| MX2023006414A (es) | Paquete de dosificacion unitaria y metodos para administrar medicaciones de perdida de peso. | |
| AR037592A1 (es) | Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno | |
| ATE509616T1 (de) | Topische pharmazeutische und/oder cosmetische dosierungssysteme | |
| JP2006504795A5 (pt) | ||
| RU2010147287A (ru) | Комбинированная композиция | |
| WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
| ATE292453T1 (de) | Antivirale arznei | |
| AR046036A1 (es) | Composiciones de risedronato y metodos para su uso | |
| RU2010109359A (ru) | Азитромицин для лечения кожных заболеваний | |
| RU2011111792A (ru) | Применение парацетамола и ибупрофена в лечении | |
| BRPI0413374A (pt) | composições para liberação de base fraca por um perìodo estendido de tempo | |
| DE69803670D1 (de) | Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung | |
| AR030551A1 (es) | Uso de nefiracetam para la fabricacion de un medicamento para eltratamiento de la neurodegeneracion y composicion farmaceutica resultante | |
| AR046042A1 (es) | Kit para uso farmaceutico | |
| RU2002129356A (ru) | Комбинация лекарственных средств для лечения головной боли, содержащая нестероидное противовоспалительное лекарственное средство | |
| ATE494239T1 (de) | Vorrichtung zum abgeben von pharmazeutischen produkten | |
| ATE257377T1 (de) | Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform | |
| RU2007132181A (ru) | ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ | |
| AR029327A1 (es) | Uso de la levobupivacaina para la preparacion de medicamentos de aplicacion en el anestesiamiento de pacientes sujetos a intervencion de cirugia mayor | |
| RU2007128308A (ru) | НОВОЕ ПРИМЕНЕНИЕ РЕКОМБИНАНТА АДЕНОВИРУСА р-53 ДЛЯ ЛЕЧЕНИЯ РАКОВЫХ ПАЦИЕНТОВ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: WARNER CHILCOTT COMPANY, LLC (PR) |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 DA LPI. |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B25E | Requested change of name of applicant rejected |
Owner name: WARNER CHILCOTT COMPANY, LLC (PR) |
|
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/03/2004, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 19A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2715 DE 17-01-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |